This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Limouzin-Lamothe MA, Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 1994; 170:618-24.10.1016/S0002-9378(94)70239-X7509570Limouzin-LamotheMAMaironNJoyceCRLe GalM.Quality of life after the menopause: influence of hormonal replacement therapy199417061824Open DOISearch in Google Scholar
Report of the International Conference on Population and Development UNFPA. 1995.1995Search in Google Scholar
Soules MR, Bremner WJ. The menopause and climacteric: endocrinologic basis and associated symptomatology. J Am Geriatr Soc. 1982; 30:547-61.10.1111/j.1532-5415.1982.tb05661.x7050219SoulesMRBremnerWJ.The menopause and climacteric: endocrinologic basis and associated symptomatology19823054761Open DOISearch in Google Scholar
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288:321-33.10.1001/jama.288.3.32112117397RossouwJEAndersonGLPrenticeRLLaCroixAZKooperbergCStefanickMLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial200228832133Open DOISearch in Google Scholar
Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008; 107: 103-11.17333341FournierABerrinoFClavel-ChapelonF.Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study20081071031110.1007/s10549-007-9523-xSearch in Google Scholar
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012; 19:257-71.22367731The 2012 hormone therapy position statement of: The North American Menopause Society2012192577110.1097/gme.0b013e31824b970aSearch in Google Scholar
Sturdee DW, Pines A, International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011; 14: 302-20.10.3109/13697137.2011.57059021563996SturdeeDWPinesAInternational Menopause Society Writing GroupArcherDFBaberRJBarlowDUpdated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health20111430220Open DOISearch in Google Scholar
Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003; 1:28.10.1186/1477-7525-1-2812914663HeinemannLAPotthoffPSchneiderHP.International versions of the Menopause Rating Scale (MRS)2003128Open DOISearch in Google Scholar
Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24:161-75.10.1016/0378-5122(96)01038-98844630HilditchJRLewisJPeterAvan MarisBRossAFranssenEA menopause-specific quality of life questionnaire: development and psychometric properties19962416175Open DOISearch in Google Scholar
EuroQol Group Executive Office. How to obtain EQ-5D 2013; Available from: http://www.euroqol.org/eq-5d-products/how-to-obtain-eq-5d.html.EuroQol Group Executive Officehttp://www.euroqol.org/eq-5d-products/how-to-obtain-eq-5d.htmlSearch in Google Scholar
SF-36 Health Survey Update [database on the Internet]. Available from: www.SF36.org.Available fromwww.SF36.orgSearch in Google Scholar
North American Menopause Society. [13 Dec, 2004]; Available from: www.menopause.org.[13 Dec, 2004]; Available fromwww.menopause.orgSearch in Google Scholar
Fallahzadeh H. Quality of life after the menopause in Iran: a population study. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2010; 19:813-9.10.1007/s11136-010-9644-220358299FallahzadehH.Quality of life after the menopause in Iran: a population study201019813920358299Open DOISearch in Google Scholar
Żołnierczuk-Kieliszek D, Kulik TB, Jarosz MJ, Stefanowicz A, Pacian A, Pacian J, Janiszewska M. Quality of life in peri- and post-menopausal Polish women living in Lublin Province – differences between urban and rural dwellers. Ann Agric Environ Med. 2012; 19:129-33.Żołnierczuk-KieliszekDKulikTBJaroszMJStefanowiczAPacianAPacianJJaniszewskaM.Quality of life in peri- and post-menopausal Polish women living in Lublin Province – differences between urban and rural dwellers20121912933Search in Google Scholar
Norozi E, Mostafavi F, Hasanzadeh A, Moodi M, Sharifirad G. Factors affecting quality of life in postmenopausal women, Isfahan, 2011. J Educ Health Promot. 2013; 2:58. 10.4103/2277-9531.12085724520556NoroziEMostafaviFHasanzadehAMoodiMSharifiradG.Factors affecting quality of life in postmenopausal women, Isfahan, 2011201325810.4103/2277-9531.120857390849124520556Open DOISearch in Google Scholar
Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas. 2002; 42:195-200.1216104310.1016/S0378-5122(02)00038-5MaartensLWKnottnerusJAPopVJ.Menopausal transition and increased depressive symptomatology: a community based prospective study200242195200Search in Google Scholar
Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004; 61:62-70.1470694510.1001/archpsyc.61.1.62FreemanEWSammelMDLiuLGraciaCRNelsonDBHollanderL.Hormones and menopausal status as predictors of depression in women in transition to menopause200461627014706945Search in Google Scholar
Whiteley J, DiBonaventura M, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt). 2013; 22:983-90.2408367410.1089/jwh.2012.3719WhiteleyJDiBonaventuraMWagnerJSAlvirJShahS.The impact of menopausal symptoms on quality of life, productivity, and economic outcomes20132298390382012824083674Search in Google Scholar
Maartens LW, Leusink GL, Knottnerus JA, Smeets CG, Pop VJ. Climacteric complaints in the community. Fam Pract. 2001; 18:189-94.10.1093/fampra/18.2.18911264270MaartensLWLeusinkGLKnottnerusJASmeetsCGPopVJ.Climacteric complaints in the community2001181899411264270Open DOISearch in Google Scholar
Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women’s experience of the menopause. Br J Obstet Gynaecol. 1996; 103: 1025-8.10.1111/j.1471-0528.1996.tb09555.x8863703PorterMPenneyGCRussellDRussellETempletonA.A population based survey of women’s experience of the menopause1996103102588863703Open DOISearch in Google Scholar
Gracia CR, Sammel MD, Freeman EW, Liu L, Hollander L, Nelson DB. Predictors of decreased libido in women during the late reproductive years. Menopause. 2004; 11:144-50.1502144310.1097/01.GME.0000082147.01218.CFGraciaCRSammelMDFreemanEWLiuLHollanderLNelsonDB.Predictors of decreased libido in women during the late reproductive years20041114450Search in Google Scholar
Pines A, Sturdee DW, MacLennan AH. Quality of life and the role of menopausal hormone therapy. Climacteric. 2012; 15:213-6.2261260610.3109/13697137.2012.655923PinesASturdeeDWMacLennanAH.Quality of life and the role of menopausal hormone therapy201215213622612606Search in Google Scholar
MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric. 2001; 4:58-74.10.1080/cmt.4.1.58.7411379379MacLennanALesterSMooreV.Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review200145874Open DOISearch in Google Scholar
Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA. 2002; 287:591-7.10.1001/jama.287.5.59111829697HlatkyMABoothroydDVittinghoffESharpPWhooleyMA.Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial2002287591711829697Open DOISearch in Google Scholar
Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ. 2008; 337:a1190. doi:10.1136/bmj.a1190.18719013WeltonAJVickersMRKimJFordDLawtonBAMacLennanAHHealth related quality of life after combined hormone replacement therapy: randomised controlled trial2008337a119010.1136/bmj.a1190Open DOISearch in Google Scholar
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003; 348:1839-54.10.1056/NEJMoa03031112642637HaysJOckeneJKBrunnerRLKotchenJMMansonJEPattersonREEffects of estrogen plus progestin on health-related quality of life200334818395412642637Open DOISearch in Google Scholar
Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol.1998; 92:982-8.9840563GreendaleGAReboussinBAHoganPBarnabeiVMShumakerSJohnsonSSymptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial199892982810.1097/00006250-199812000-00019Search in Google Scholar